Post-ENRICH IIS Overview
There is still much to be learned from the results of the ENRICH clinical trial which recently announced a 98% probability MIPS for ICH removal is superior to medical management. Despite this success, there is more to discover, especially surrounding anterior basal ganglia hemorrhage and less developed aspects of providing appropriate care for each patient. Thus, the NICO IIS Program has now expanded to include Post-ENRICH Areas of Interest.
View our Post-ENRICH Areas of Interest
NICO continues to be interested in providing support for researchers and physicians across a wide range of neuro-specialties committed to building clinical and scientific data to achieve better outcomes for patients using NICO technologies in Minimally Invasive Parafascicular Surgery (MIPS).
To submit, click HERE.
Questions
Should you have specific questions about the process or program, please contact us.